China Resources Sanjiu Medical & Pharmaceutical Co Ltd Financial Flexibility Index
China Resources Sanjiu Medical & Pharmaceutical Co Ltd financial flexibility index. China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Financial Flexibility Index of 0.16x as of December 2025. Free cash flow of CN¥3.15 Billion (operating CF CN¥2.60 Billion minus capex CN¥545.33 Million) represents 0% of total liabilities (CN¥20.03 Billion). Explore China Resources Sanjiu Medical & Pharmac (000999) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2025)
Financial flexibility index of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2025. Historical Financial Flexibility Index trend for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 27 annual periods. Check China Resources Sanjiu Medical & Pharmac cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Financial Flexibility Index by Year (1999–2025)
China Resources Sanjiu Medical & Pharmaceutical Co Ltd financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see China Resources Sanjiu Medical & Pharmac operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | CN¥6.78 Billion | CN¥5.51 Billion | CN¥20.03 Billion | ▼ -3.3% |
| 2024 | 0.35x | CN¥5.19 Billion | CN¥4.40 Billion | CN¥14.83 Billion | ▲ +10.2% |
| 2023 | 0.32x | CN¥5.05 Billion | CN¥4.19 Billion | CN¥15.89 Billion | ▼ -23.0% |
| 2022 | 0.41x | CN¥3.96 Billion | CN¥3.01 Billion | CN¥9.59 Billion | ▲ +31.3% |
| 2021 | 0.31x | CN¥2.76 Billion | CN¥1.88 Billion | CN¥8.77 Billion | ▼ -10.6% |
| 2020 | 0.35x | CN¥2.85 Billion | CN¥2.22 Billion | CN¥8.10 Billion | ▲ +16.6% |
| 2019 | 0.30x | CN¥2.51 Billion | CN¥1.97 Billion | CN¥8.32 Billion | ▼ -17.7% |
| 2018 | 0.37x | CN¥2.51 Billion | CN¥1.91 Billion | CN¥6.86 Billion | ▲ +12.6% |
| 2017 | 0.33x | CN¥1.97 Billion | CN¥1.60 Billion | CN¥6.07 Billion | ▼ -10.1% |
| 2016 | 0.36x | CN¥1.75 Billion | CN¥1.39 Billion | CN¥4.83 Billion | ▼ -1.2% |
| 2015 | 0.37x | CN¥1.59 Billion | CN¥1.26 Billion | CN¥4.35 Billion | ▼ -11.9% |
| 2014 | 0.42x | CN¥1.53 Billion | CN¥1.18 Billion | CN¥3.67 Billion | ▼ -13.8% |
| 2013 | 0.48x | CN¥1.82 Billion | CN¥1.47 Billion | CN¥3.78 Billion | ▼ -13.8% |
| 2012 | 0.56x | CN¥1.72 Billion | CN¥1.21 Billion | CN¥3.07 Billion | ▲ +12.7% |
| 2011 | 0.50x | CN¥1.36 Billion | CN¥954.90 Million | CN¥2.75 Billion | ▼ -17.5% |
| 2010 | 0.60x | CN¥1.12 Billion | CN¥848.28 Million | CN¥1.86 Billion | ▼ -3.6% |
| 2009 | 0.62x | CN¥1.05 Billion | CN¥855.05 Million | CN¥1.68 Billion | ▼ -54.2% |
| 2008 | 1.36x | CN¥2.32 Billion | CN¥1.12 Billion | CN¥1.70 Billion | ▲ +715.8% |
| 2007 | 0.17x | CN¥832.07 Million | CN¥605.30 Million | CN¥4.98 Billion | ▲ +34.5% |
| 2006 | 0.12x | CN¥561.32 Million | CN¥425.51 Million | CN¥4.52 Billion | ▲ +863.5% |
| 2005 | 0.01x | CN¥59.97 Million | CN¥22.83 Million | CN¥4.65 Billion | ▲ +109.9% |
| 2004 | -0.13x | CN¥-635.05 Million | CN¥-719.63 Million | CN¥4.89 Billion | ▼ -515.7% |
| 2003 | 0.03x | CN¥163.97 Million | CN¥28.09 Million | CN¥5.25 Billion | ▼ -81.9% |
| 2002 | 0.17x | CN¥668.80 Million | CN¥496.12 Million | CN¥3.88 Billion | ▲ +131.0% |
| 2001 | 0.07x | CN¥272.26 Million | CN¥153.44 Million | CN¥3.65 Billion | ▼ -52.0% |
| 2000 | 0.16x | CN¥437.44 Million | CN¥266.86 Million | CN¥2.81 Billion | ▼ -25.8% |
| 1999 | 0.21x | CN¥194.06 Million | CN¥120.63 Million | CN¥925.96 Million | — |